4//SEC Filing
Chelsea Therapeutics International, Ltd. 4
Accession 0001181431-09-004810
CIK 0001333763operating
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:00 PM ET
Size
7.5 KB
Accession
0001181431-09-004810
Insider Transaction Report
Form 4
HARDMAN NORMAN PHD
Director
Transactions
- Award
Stock Option (Right to Buy)
2009-01-22+30,000→ 30,000 totalExercise: $1.78Exp: 2019-01-22→ Common Stock (30,000 underlying)
Holdings
- 5,000
Common Stock
- 35,000
Stock Option (Right to Buy)
Exercise: $4.80Exp: 2018-04-10→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Option vests in four equal annual installments beginning on January 22, 2010.
- [F2]Option vests in four equal annual installments beginning on April 10, 2009.
Documents
Issuer
Chelsea Therapeutics International, Ltd.
CIK 0001333763
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333763
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:00 PM ET
- Size
- 7.5 KB